```html
Half-Year Financial Statements Close with Balanced EBITDA Trauma with Positive EBITDA
Aap Implantate AG Announces Key Financial Results for Half-Year 2023
Strong Web Sales Growth in Q2 and H1
aap Implantate AG (XETRA: AAQDE), a global medical device company focused on innovative spinal implants and instruments, has reported strong sales growth in its web segment for the first half of 2023.
Web sales grew by 14% in the second quarter of 2023 compared to the same period last year. For the first half of the year, web sales grew by 10% year-over-year.
"Our strong web sales growth is a testament to the increasing demand for our innovative products and our commitment to meeting the needs of our customers," said Dr. Tilman Bruch, CEO of aap Implantate AG.
"We are particularly encouraged by the performance of our Trauma segment, which delivered a positive EBITDA margin in the first half of the year."
aap Implantate AG invites investors and analysts to access the comprehensive 2023 annual report and investor relations information on.
```
Comments